Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial...

[PDF] mdpi.com

Antiandrogens as Therapies for COVID-19: A Systematic Review

M Cani, S Epistolio, G Dazio, M Modesti, G Salfi… - Cancers, 2024 - mdpi.com
Simple Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic recently represented an unexpected global issue. Due to its rapid spread and …
被引用次数：5 相关文章 所有 13 个版本
[PDF] cpu.edu.cn

雄激素受体拮抗剂普克鲁胺——具有双重作用机制的抗COVID-19 新药

童友之， 马连东 - 药学进展, 2023 - pps.cpu.edu.cn
普克鲁胺是由开拓药业研发的第2 代雄激素受体拮抗剂. 针对COVID-19,
该药具有双重作用机制, 能通过下调血管紧张素转换酶2 和跨膜丝氨酸蛋白酶2 …
相关文章 所有 2 个版本
[PDF] hal.science

BIOTHERAPIES et VOIE NASALE: développement et application dans la polypose nasosinusienne

M Fieux - 2023 - hal.science
Background: Multiple biologics have been recently suggested as a new treatment for chronic
rhinosinusitis with nasal polyps (CRSwNP). Currently, only two drugs can be prescribed in …
相关文章